In an interview with Ars Technica in August, Brigid Groves, vice president of professional affairs for the American Pharmacists Association (APhA) signaled that efforts to limit access to COVID-19 vaccines is concerning to APhA, which is the leading organization representing pharmacists. “We are concerned about that because the data and evidence point to the fact...